ITGR Stock Analysis: Buy, Sell, or Hold?
ITGR - Integer Holdings Corporation
$125.20
-0.01 (-0.01%)
âŧ
5d:
-0.05%
30d:
+28.41%
90d:
+39.11%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ITGR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ITGR is fairly priced but lacks strong directional signals. At 11.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ITGR is fairly priced but lacks strong directional signals. At 11.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$132.48
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$82.26
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ITGR is currently trading at $125.20, which is considered slightly high relative to its 30-day fair value range of $98.40 to $125.89. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.2) compared to its historical average (13.3). At these levels, the market is pricing in 11.1% annual earnings growth.
Technical Outlook: Technically, ITGR is in a strong uptrend. The price is currently testing key support at $124.90. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ITGR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ITGR is in a strong uptrend. The price is currently testing key support at $124.90. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ITGR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$98.40 -
$125.89
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.4%
Protect Your Profits
ITGR is technically overbought (RSI 82). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($121.80)
- BULLISH: Expecting earnings turnaround to 11.1% growth with -2.6% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$98.40 -
$125.89
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$124.90
Resistance Level
$125.47
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.23
Wall Street Target
$121.80
(-2.7%)
Revenue Growth (YoY)
-2.6%
Earnings Growth (YoY)
-33.7%
Profit Margin
7.0%
Valuation Premium vs History
+11.1% premium
PE vs Historical
18.2 vs 13.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.1%
(market-implied from PE analysis)
1-Year Target
$139.10
(+11%)
2-Year Target
$154.54
(+23%)
3-Year Target
$171.69
(+37%)
3-Yr Target (if PE normalizes)
(PE: 18â13)
PE COMPRESSION
$125.28
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 11.5%)
$190.86
(+52%)
Base:
(SPY PE: 18.2, Growth: 11.5%)
$173.34
(+38%)
Bear:
(PE: 13.3, Growth: 11.5%)
$126.48
(+1%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 34.21 | Current EPS (TTM): $3.66
Bull Case
$258.48
(+107%)
Analyst growth 87.7%, PE expands to 37.6
Base Case
$234.98
(+88%)
Market implied 87.7%, PE stable at 34.2
Bear Case
$85.14
(-32%)
Severe decline -20.0%, PE contracts to 29.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 2:25 PM ET
Data refreshes hourly during market hours. Next update: 3:25 PM
Data refreshes hourly during market hours. Next update: 3:25 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ITGR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Tommy P Thomas
SELL
825 shares
2026-03-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
Advanced ITGR Option Strategies
Professional options setups generated by AI based on today's ITGR price and gamma walls.
